Litao Melissa Kaori Silva, Hayes Don, Chiwane Saurabh, Nogee Lawrence M, Kurland Geoffrey, Guglani Lokesh
Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan.
Section of Pulmonary Medicine, Lung Transplant Program, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio.
Pediatr Pulmonol. 2017 Jan;52(1):57-68. doi: 10.1002/ppul.23493. Epub 2016 Jun 30.
Mutations of the Surfactant Protein C (SPC) gene (SFTPC) have been associated with childhood interstitial lung disease (chILD) with variable age of onset, severity of lung disease, and outcomes. We report a novel mutation in SFTPC [c.435G->A, p.(Gln145)] that was associated with onset of symptoms in early infancy, progressive respiratory failure with need for prolonged mechanical ventilatory support, and eventual lung transplant at 1 year of age. While the mutation was not predicted to alter the amino acid sequence of the SP-C precursor protein, analysis of SP-C transcripts demonstrated skipping of exon 4. Because of limited data about the outcomes of infants with SFTPC mutations, we conducted a systematic review of all the SFTPC mutations reported in the literature in order to define their presenting features, clinical and radiologic features, and outcomes. Further advances in our understanding of chILD and creation of an international registry will help to track these patients and their outcomes. Pediatr Pulmonol. 2017;52:57-68. © 2016 Wiley Periodicals, Inc.
表面活性蛋白C(SPC)基因(SFTPC)的突变与儿童间质性肺疾病(chILD)相关,其发病年龄、肺部疾病严重程度和预后各不相同。我们报告了SFTPC基因的一个新突变[c.435G->A,p.(Gln145)],该突变与婴儿早期症状发作、需要长期机械通气支持的进行性呼吸衰竭以及1岁时最终进行肺移植有关。虽然该突变预计不会改变SP-C前体蛋白的氨基酸序列,但对SP-C转录本的分析显示外显子4跳跃。由于关于SFTPC基因突变婴儿预后的数据有限,我们对文献中报道的所有SFTPC基因突变进行了系统综述,以确定其表现特征、临床和放射学特征以及预后。我们对chILD认识的进一步进展以及建立国际登记册将有助于追踪这些患者及其预后。《儿科肺科杂志》。2017年;52:57 - 68。©2016威利期刊公司